Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,640 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies.
Yamamoto KN, Nakamura A, Liu LL, Stein S, Tramontano AC, Kartoun U, Shimizu T, Inoue Y, Asakuma M, Haeno H, Kong CY, Uchiyama K, Gonen M, Hur C, Michor F. Yamamoto KN, et al. Among authors: stein s. PLoS One. 2019 Apr 26;14(4):e0215409. doi: 10.1371/journal.pone.0215409. eCollection 2019. PLoS One. 2019. PMID: 31026288 Free PMC article.
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.
Janiszewska M, Stein S, Metzger Filho O, Eng J, Kingston NL, Harper NW, Rye IH, Alečković M, Trinh A, Murphy KC, Marangoni E, Cristea S, Oakes B, Winer EP, Krop IE, Russnes HG, Spellman PT, Bucher E, Hu Z, Chin K, Gray JW, Michor F, Polyak K. Janiszewska M, et al. Among authors: stein s. JCI Insight. 2021 Jun 8;6(11):e147617. doi: 10.1172/jci.insight.147617. JCI Insight. 2021. PMID: 33886505 Free PMC article.
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.
Filho OM, Viale G, Stein S, Trippa L, Yardley DA, Mayer IA, Abramson VG, Arteaga CL, Spring LM, Waks AG, Wrabel E, DeMeo MK, Bardia A, Dell'Orto P, Russo L, King TA, Polyak K, Michor F, Winer EP, Krop IE. Filho OM, et al. Among authors: stein s. Cancer Discov. 2021 Oct;11(10):2474-2487. doi: 10.1158/2159-8290.CD-20-1557. Epub 2021 May 3. Cancer Discov. 2021. PMID: 33941592 Free PMC article. Clinical Trial.
Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing.
Fang C, Zhong H, Lin Y, Chen B, Han M, Ren H, Lu H, Luber JM, Xia M, Li W, Stein S, Xu X, Zhang W, Drmanac R, Wang J, Yang H, Hammarström L, Kostic AD, Kristiansen K, Li J. Fang C, et al. Among authors: stein s. Gigascience. 2018 Mar 1;7(3):1-8. doi: 10.1093/gigascience/gix133. Gigascience. 2018. PMID: 29293960 Free PMC article.
NIST Mass Spectral Libraries in the Context of the Circular Economy of Plastics.
Simón-Manso Y, Erisman EP, Mak TD, Burke MC, Zuber A, Yang X, Liang Y, Neta P, Bukhari T, Williams AJ, Young JA, Wickramasekara S, Wallace WE, Stein SE. Simón-Manso Y, et al. Among authors: stein se. J Am Soc Mass Spectrom. 2025 Jan 3. doi: 10.1021/jasms.4c00349. Online ahead of print. J Am Soc Mass Spectrom. 2025. PMID: 39752563
1,640 results